INIS
monitoring
100%
adults
100%
diseases
100%
children
100%
populations
100%
receptors
100%
therapy
66%
pediatrics
66%
tools
33%
reviews
33%
hepatitis
33%
infants
33%
adolescents
33%
age groups
33%
lupus
33%
Medicine and Dentistry
Diagnosis
100%
Membranous Glomerulonephritis
100%
Monitoring
100%
Therapeutic Procedure
100%
Child
27%
Adult
27%
Diseases
18%
Nephrotic Syndrome
18%
Pediatrics
18%
Immunosuppressive Treatment
9%
Combination Therapy
9%
Autoantibody
9%
Age Groups
9%
Rituximab
9%
Infection
9%
Hepatitis B
9%
Antigen Antibody Complex
9%
Thrombospondin
9%
Focal Segmental Glomerulosclerosis
9%
Minimal Change Disease
9%
Infant
9%
Adolescent
9%
Pharmacology, Toxicology and Pharmaceutical Science
Membranous Glomerulonephritis
100%
Phospholipase A2 Receptor
100%
Diseases
27%
Nephrotic Syndrome
18%
Rituximab
9%
Lupus Vulgaris
9%
Infection
9%
Immunosuppressive Agent
9%
Autoantibody
9%
Hepatitis B
9%
Thrombospondin
9%
Focal Glomerulosclerosis
9%